A practical reference on GLP-1 analog: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-11 and is reviewed periodically as new material appears.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | Not a small molecule |
| Backbone substitutions | Non-natural residue at position 8, arginine at position 34 | Slows enzymatic cleavage |
| Side chain | C18 fatty diacid with PEG linker | Enables albumin binding |
| Approximate molecular mass | 4114 Da | Varies slightly with salt form |
| Reported half-life | About one week | Longer than native GLP-1 by orders of magnitude |
Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.
GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Solid peptide material is generally kept at reduced temperature to limit degradation. Short-term storage at 2 to 8 degrees Celsius is common, while longer archival storage at minus 20 degrees Celsius or below is typical for lyophilised powder. Vials should remain sealed and protected from light, because ultraviolet exposure can oxidise susceptible residues. Repeated freeze-thaw cycles are avoided, as they promote aggregation and loss of soluble material. Solutions are less stable than solids and are usually prepared close to the time of use.
Reversed-phase high-performance liquid chromatography is widely used to assess purity and to separate the parent peptide from related substances. Mass spectrometry confirms identity and can resolve modifications that differ by a few daltons. Size-exclusion chromatography detects dimers and higher aggregates, which are relevant to both stability and immunogenicity questions. Peptide mapping with enzymatic digestion locates specific modifications along the sequence. Circular dichroism provides a secondary-structure profile, although it gives limited information about local conformational changes.
When combined with an appropriate exercise program, dietary supplementation with β-hydroxy β-methylbutyrate (HMB) has been shown to dose-dependently augment gains in muscle hypertrophy (i.e., the size of a muscle), muscle strength, and lean body mass, reduce exercise-induced skeletal muscle damage, and expedite recovery from high-intensity exercise. HMB is believed to produce these effects by increasing muscle protein synthesis and decreasing muscle protein breakdown by various mechanisms, including activation of the mechanistic target of rapamycin (mTOR) and inhibition of the proteasome in skeletal muscles. The inhibition of exercise-induced skeletal muscle damage by HMB is affected by the time that it is used relative to exercise. The greatest reduction in skeletal muscle damage from a single bout of exercise appears to occur when calcium HMB is ingested 1–2 hours prior to exercise.
Throughout late November and early December, the Cubans focused on fighting the FNLA in the north, and stopping an abortive incursion by Zaire on behalf of that movement. Thereafter, they refocused on putting an end to the SADF advances in the south. The South African and Cuban forces engaged in a series of bloody, but inconclusive skirmishes and battles throughout late December. However, by this point word of the SADF's involvement had been leaked to the international press, and photographs of SADF armour behind UNITA lines were appearing in several European newspapers. This proved to be a major political setback for the South African government, which was almost universally condemned for its interference in a black African country. Moreover, it spurred influential African states such as Nigeria and Tanzania to recognise the MPLA as the sole legitimate government of Angola, as that movement's struggle against an apparent act of South African aggression gave it legitimacy at the OAU. South Africa appealed to the United States for more direct support, but when the CIA's role in arming the FNLA also became public, the US Congress terminated and disavowed the programme. In the face of regional and international condemnation, the SADF made the decision around Christmas of 1975 to begin withdrawing from Angola. The withdrawal commenced in February 1976 and formally ended a month later. As the FNLA and UNITA lost their logistical backing from the CIA and the direct military support of the SADF, they were forced to abandon much of their territory to a renewed FAPLA offensive.
mitotic rounding The process by which most animal cells undergo an overall change in shape during or preceding mitosis, abandoning the various complex or elongated shapes characteristic of interphase and rapidly contracting into a rounded or spherical morphology that is more conducive to cell division. This phenomenon has been observed both in vivo and in vitro.
Polyphenols are natural products with "several hydroxyl groups on aromatic rings", including four principal classes: phenolic acids, flavonoids, stilbenes, and lignans. Flavonoids can be grouped as flavones, flavonols, flavanols, flavanones, isoflavones, proanthocyanidins, and anthocyanins. Particularly abundant flavanoids in foods are catechin (tea, fruits), hesperetin (citrus fruits), cyanidin (red fruits and berries), daidzein (soybean), proanthocyanidins (apple, grape, cocoa), and quercetin (onion, tea, apples). Polyphenols also include phenolic acids, such as caffeic acid, and lignans, which are derived from phenylalanine present in flax seed and other cereals.
Sources: en.wikipedia.org
== See also == Farkas, Etelka; Buglyó, Péter (2017). "Chapter 8. Lead(II) Complexes of Amino Acids, Peptides, and Other Related Ligands of Biological Interest". In Astrid, S.; Helmut, S.; Sigel, R. K. O. (eds.). Lead: Its Effects on Environment and Health. Metal Ions in Life Sciences. Vol. 17. de Gruyter. pp. 201–240. doi:10.1515/9783110434330-008. PMID 28731301. pp. 228–230 Dunaliella
Keloids grow extensively beyond the wound margins and tend to persist or even worsen over time. They are relatively difficult to treat due to their high risk of recurrence. Keloids are more common in people with darker skin tones and often occur in individuals with a genetic predisposition. Keloids are the most extreme type of scarring since minor wounds such as insect bites or piercings can all lead to an elevated tissue area. Patients may experience psychological trauma if their scars are not well-controlled. Therefore, the prevention of wound formation is crucial to them. They should avoid undergoing any unnecessary invasive procedures or cosmetic surgeries. The beneficial effects of silicone gel sheeting on the treatment and prevention of these two scars have been confirmed. Since most patients develop hypertrophic and keloid scars within 3 months after surgery or injury, the silicone gel sheeting therapy should be started in the early repair phase to achieve an optimal therapeutic effect. The maturity of scars takes over a year; therefore, silicone treatment is also effective in scars aged over 12 months. The therapy usually requires 6 to 12 months of constant wear to achieve optimum results. Recent data suggest that the combination of silicone gel sheeting and pressure therapy can improve post-traumatic scar healing.
== Social disparities in glaucoma care and research == A study conducted in the UK showed that people living in an area of high deprivation were likely to be diagnosed in the later stage of the disease. It also showed that there was a lack of professional ophthalmic services in the area of high deprivation. A study in 2017 shows that there is a huge difference in the volume of glaucoma testing depending on the type of insurance in the US. Researchers reviewed 21,766 persons aged ≥ 40 years old with newly diagnosed open-angle glaucoma (OAG) and found that Medicaid recipients had substantially lower volume of glaucoma testing performed compared to patients with commercial health insurance. Results from a meta-analysis of 33,428 primary open-angle glaucoma (POAG) participants published in 2021 suggest that there are substantial ethnic and racial disparities in clinical trials in the US. Although ethnic and racial minorities have a higher disease burden, the 70.7% of the study participants was White as opposed to 16.8% Black and 3.4% Hispanic/Latino.
==== Nutritional supplements ==== OI is a genetic disorder and is not caused by insufficient intake of any vitamin or mineral; supplementation cannot cure OI. Nevertheless, people with OI tend to be severely deficient in vitamin D at much higher rates than the general population, and the cause of this is not well understood. The severity of the deficiency and the likelihood of its occurrence is thought to be related to severity of OI. Vitamin D supplementation may be recommended, at least until levels of 25(OH)D3 in a patient's blood return to normal. Vitamin D deficiency is also a concern as it may decrease the benefit of bisphosphanates.
=== Mutations === Cystinosis is presented in patients with a range of CTNS mutations; as of 2017, over 100 have been identified. The most common mutation is a 57,257 base pair deletion commonly referred to as the 57 kb deletion. This was formally known as the 65 kb deletion; a misnomer originating from early incorrect estimates. Other reported mutations include other deletions, missense mutations, and in-frame deletions and insertions. The type and extent of mutation determines the type and severity of cystinosis in the carrier. This is a result of the degree of transport inhibition caused by the misfolding of cystinosin. For example, mild cystinosis is typically associated with mutations that do not affect the amino acids in the transmembrane domains of cystinosin. In contrast, infantile nephropathic cystinosis, the most severe form of the disease, is most commonly associated with a total loss of activity. Gene deletion resulting in the absence of either of the sorting motifs results in the delocalization of cystinosin to the cellular plasma membrane.
Sources: en.wikipedia.org
Duterte has Buerger's disease, an inflammation of blood vessels, mostly in the limbs, and Barrett's esophagus, wherein esophageal cells are gradually replaced by gastrointestinal cells. He has denied rumors of throat cancer. Duterte admitted in December 2016 that he had been a user of the addictive opioid drug Fentanyl. He said that a doctor prescribed the drug to alleviate back pain and headaches, but that he would take more than he was prescribed. Duterte later denied that he was a drug addict, and a spokesman stated that he was not affected by side-effects of the drug, which include confusion, anxiety, and hallucinations. Duterte has boasted about his use of Viagra: "When I was young, I could do overnight, which is more expensive. When I got old, I could do short time only because I have such a short time left. After one erection, that's it. No more. Without Viagra, it's even more difficult." A psychological assessment of Duterte was commissioned by a doctor named Natividad Dayan during Duterte's marriage annulment to Elizabeth Zimmerman in July 1998. The result was that Duterte (then Davao City mayor) was found to have "antisocial narcissistic personality disorder", exemplified by "gross indifference, insensitivity and self-centeredness", and a "grandiose sense of self-entitlement and manipulative behaviors".
=== Quantitative proteomics === A central theme of Borchers' work is the use of multiple reaction monitoring (MRM) mass spectrometry with stable isotope-labelled internal standard peptides to measure the absolute concentrations of proteins in complex biological samples such as blood plasma and tissues. His groups developed standardized, multiplexed LC-MRM assay panels for the quantitation of large numbers of proteins, characterizing them according to the assay-validation guidelines of the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC). He was among the authors of a 2009 CPTAC multi-laboratory study in Nature Biotechnology that assessed the reproducibility, dynamic range and detection limits of MRM-based protein measurements across laboratories and instrument platforms. In a 2024 study, his group and collaborators designed and validated MRM assays for the quantitation of 2,118 proteins across 20 mouse organs and tissues, releasing the assays and reference data through an open-access database called MouseQuaPro. He also worked on immuno-MALDI (iMALDI), a method that couples antibody-based enrichment of target peptides with MALDI mass spectrometry to quantify low-abundance proteins in clinical samples. He is the named inventor on a United States patent covering the underlying quantitation method, filed in 2003, granted in 2010 and assigned to the University of North Carolina at Chapel Hill.
Since the end of the Cold War, coups have become rarer, and more likely to be followed by democratization. Coups still often simply replace one autocracy with another one (with the new autocratic regime usually more repressive, in an attempt to prevent another coup) or have no effect on regime type. As of 2017, there was debate about whether coups in autocracies should now be considered to promote democratization, on average, or if countries' chances of democratization are still unchanged or worsened by coups (since democratization can take place without a coup). One reason for the increase in the chance of democratization is that a higher proportion of coups (half of post-Cold-War coups) now take place in democracies (a higher percentage of countries are also now democracies). Democratic countries often rebound from coups quickly, restoring democracy, but coups in a democracy are a sign of poor political health, and increase the risk of future coups and loss of democracy. The dataset is small, so statistical significance varies depending on the model used, as of 2017; debate will end if data on more coups makes the pattern clear. The post-Cold-War increase in the chances of post-coup democratization may partly be due to the incentives created by international pressure and financing. US law, for instance, automatically cuts off all aid to a country if there is a military coup. According to a 2020 study, "external reactions to coups play important roles in whether coup leaders move toward authoritarianism or democratic governance.
KDEL receptors initiate the mechanism by which proteins are transported from the Golgi to the ER. These proteins were originally from the ER and they escaped into the cis-Golgi. The KDEL signal sequence is recognized by KDEL receptors, which are commonly located in the cis-Golgi, lysosomes, and secretory vesicles. These receptors are recycled during each transport cycle. KDEL receptor binding is dependent on pH, in which the ligand (target protein) binds strongly to the receptor in the cis-Golgi due to the unique low pH (6, in in vitro experiments pH 5 shows strongest binding) characteristic of the biochemical environment of the cis-Golgi network. As the vesicle that contains the KDEL receptor reaches the ER, the receptor is inactive due to the high pH (7.2-7.4) of the ER, resulting in the release of the target protein/ligand. A study conducted by Becker et al. demonstrated through experimentation and simulation that KDEL receptors/cargo clustering at the cell surface is caused by the transport of cargo-synchronized receptors from and to the plasma membrane. The video on the right demonstrates an experiment conducted by Becker et al. demonstrating the dynamics of the KDEL receptor clustering's time dependence with a full experiment from start to finish (60 minutes). Within the paper, the authors note the importance of understanding the mechanism of action of the receptor clustering and dynamic reorganization because of its potential understanding to use for designing targeted therapeutics.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.
Albumin binding keeps a large fraction of the compound in a slowly released reservoir within the bloodstream. Plasma levels decline gradually rather than falling sharply after each administration. That profile supports dosing intervals measured in days instead of hours.
The active peptide sequence is the same in both formats. The oral version adds an absorption enhancer that is not present in the injected solution. Differences in excipients and formulation affect uptake rather than the identity of the active molecule.
Native GLP-1 is a short-lived peptide cleared within one to two minutes by dipeptidyl peptidase-4 and related enzymes. Semaglutide keeps the receptor-binding backbone but adds substitutions and a lipid chain. These changes block the main cleavage site and allow reversible albumin binding, extending the half-life to roughly 165 hours.